Abstract:Oromucosal drug delivery, both local and transmucosal (buccal), is an effective alternative to traditional oral and parenteral dosage forms because it increases drug bioavailability and reduces systemic drug toxicity. The oral mucosa has a good blood supply, which ensures that drug molecules enter the systemic circulation directly, avoiding drug metabolism during the first passage through the liver. At the same time, the mucosa has a number of barriers, including mucus, epithelium, enzymes, and immunocompetent cells, that are designed to prevent the entry of foreign substances into the body, which also complicates the absorption of drugs. The development of oromucosal drug delivery systems based on mucoadhesive biopolymers and their derivatives (especially thiolated and catecholated derivatives) is a promising strategy for the pharmaceutical development of safe and effective dosage forms. Solid, semi-solid and liquid pharmaceutical formulations based on biopolymers have several advantageous properties, such as prolonged residence time on the mucosa due to high mucoadhesion, unidirectional and modified drug release capabilities, and enhanced drug permeability. Biopolymers are non-toxic, biocompatible, biodegradable and may possess intrinsic bioactivity. A rational approach to the design of oromucosal delivery systems requires an understanding of both the anatomy/physiology of the oral mucosa and the physicochemical and biopharmaceutical properties of the drug molecule/biopolymer, as presented in this review. This review summarizes the advances in the pharmaceutical development of mucoadhesive oromucosal dosage forms (e.g., patches, buccal tablets, and hydrogel systems), including nanotechnology-based biopolymer nanoparticle delivery systems (e.g., solid lipid particles, liposomes, biopolymer polyelectrolyte particles, hybrid nanoparticles, etc.).

Application of in situ formed poloxamer gel for mucous membrane administration

An Overview on Thermosensitive Oral Gel Based on Poloxamer 407

Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview

Amino-functionalized Poloxamer 407 with Both Mucoadhesive and Thermosensitive Properties: Preparation, Characterization and Application in a Vaginal Drug Delivery System

Preparation of Polysaccharide Microgels and Application in Sustained and Controlled Release Drug Delivery Systems

Formulation strategies to modulate drug release from poloxamer based in situ gelling systems

Advances of Poloxamer 407 in Situ Gel Used As Drug Carrier

Poloxamer-Based Hydrogel as Drug Delivery System: How Polymeric Excipients Influence the Chemical-Physical Properties

Progress of in situ Gel for Sustained-release Drug Delivery System

Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.

Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview

Effect Of Carrageenan On Poloxamer-Based In Situ Gel For Vaginal Use: Improved In Vitro And In Vivo Sustained-Release Properties

In Vivo Evaluation of an In-Situ Hydrogel System for Vaginal Administration.

Mucoadhesive and Rheological Studies on the Co-Hydrogel Systems of Poly(Ethylene Glycol) Copolymers with Fluoroalkyl and Poly(Acrylic Acid)

Application of Poloxamer for In Situ Eye Drop Modeling by Enrichment with Propolis and Balsam Poplar Buds Phenolic Compounds

Recent Trends in Pharmaceutical R & D

The use of mucoadhesive polymers in vaginal drug delivery systems

Rapid in situ forming PEG hydrogels for mucosal drug delivery

Preparation and Evaluation of Poloxamer/Carbopol In-Situ Gel Loaded with Quercetin: In-Vitro Drug Release and Cell Viability Study

Research and Application of Temperature-sensitive in Situ Gel Drug Delivery Systems